BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 28569782)

  • 21. Long non-coding RNA BRE-AS1 inhibits proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating miR-106b-5p.
    Zou G; Guo L; Shen S; Song Z; Ouyang Z; Yu Y
    Histol Histopathol; 2024 Jun; 39(6):729-737. PubMed ID: 37530129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
    Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
    Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
    Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
    Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
    Guo R; Zou B; Liang Y; Bian J; Xu J; Zhou Q; Zhang C; Chen T; Yang M; Wang H; Pei F; Xu Z
    Cell Death Dis; 2021 Jul; 12(7):689. PubMed ID: 34244473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
    Zhou X; Zeng B; Li Y; Wang H; Zhang X
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.
    Zhou J; Li P; Feng J; Wu Q; You S
    Biochem Genet; 2023 Oct; 61(5):2004-2019. PubMed ID: 36917325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
    Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
    Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
    Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
    Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
    Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
    Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31767633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
    Yan Z; Bi M; Zhang Q; Song Y; Hong S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
    Jiao M; Guo H; Chen Y; Li L; Zhang L
    Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.